Page 317 - Read Online

Ramadori. Hepatoma Res 2020;6:28 I http://dx.doi.org/10.20517/2394-5079.2020.43 Page 9 of 10

the risk nomogram in Wuhan and Guangdong, China. Clin Infect Dis 2020; Epub ahead of print. doi: 10.1093/cid/ciaa443.
17. Cohn EJ, Oncley JL, Strong LE, Hughes WL, Armstrong SH. Chemical, clinical, and immunological studies on the products of human
plasma fractionation. I. the characterization of the protein fractions of human plasma. J Clin Invest 1944;23:417-32.
18. Scatchard G, Batchelder AC, Brown A. Chemical,clinical and immunological studies on the products of human plasma fractonation. VI.
The osmotic pressure of plasma and of serum albumin. J Clin Investt 1944;23:458-64.
19. Post J, Patek AJ. Serum proteins in relation to liver disorders. Bull N Y Acad Med 1943;19:815-30.
20. Thorn GW, Armstrong SH, Davemport VD. Chemical, clinical, and immunological studies on the products of human plasma fractionation.
XXXI. The use of salt-poor concentrated human serum albumin solution in the treatment of hepatic cirrhosis. J Clin Invest 1946;25:304-
23.
21. Kunkel HG, Labby DH, Ahrens EH, Shank RE, Hoagland CL. The use of concentrated human serum albumin in the tretment of cirrhosis
oft he liver. J Clin Invest 1948;27:305-19.
22. Wilkinson P, Sherlock S. The effect of repeated albumin infusions in patients with cirrhosis. Lancet 1962;2:1125-9.
23. Gentilini P, Casini-Raggi V, Di Fiore G, Romanelli RG, Buzzelli G, et al. Albumin improves the response to diuretics in patients with
cirrhosis and ascites: results of a randomized, controlled trial. J Hepatol 1999;30:639-45.
24. Caraceni P, Riggio O, Angeli P, Alessandria C, Neri S, et al. Long-term albumin administration in decompensated cirrhosis (ANSWER):an
open label randomized trial. Lancet 2018;391:2417-29.
25. Patek AJ, Mankin H, Colcher H, Lowell A, Earle DP. The effects of intravenous injection of concentrated human serum albumin upon
blood plasma,ascites and renal functions in three patients with cirrhosis oft he liver. J Clin Invest 1948;27:135-44.
26. Schindler C, Ramadori G. Albumin substitution improves urinary sodium excretion and diuresis in patients with liver cirrhosis and
refractory ascites. J Hepatol 1999;31:1132.
27. Schindler C, Ramadori G. Humanalbumingaben zur Verbesserung der renalen Ausscheidungsfunktion bei Patienten mit
therapierefractärem Aszites-Ein Erfahrungsbericht. Leber Magen Darm 1999;4:183-7.
28. Nolte W, Ramadori G. Albumin for refractory ascites. Gastroenterology 2003;125:1283-4.
29. Trotter J, Pieramici E, Everson GT. Chronic albumin infusions to achieve diuresis in patients with ascites who are not candidates for
transjugular intrahepatic portosystemic shunt(TIPS). Dig Dis Sci 2005;50:1356-60.
30. Bajaj JS, Tandon P, O’Leary JG, Biggins SW, Wong F, et al. The impact of albumin use on resolution of hyponatremia in hospitalized
patients with cirrhosis. Am J Gastroenterol 2018;113:1339.
31. Bai Z, Bernardi M, Yoshida EM, Li H, Guo X, et al. Albumin infusion may decrease the incidence and severity of overt hepatic
encephalopathy in liver cirrhosis. Aging (Albany NY) 2019;11:8502-25.
32. Kaplan DE, Dai F, Aytaman A, Baytarian M, Fox R, et al.; VOCAL Study Group. Development and performance of an algorithm to
estimate the child-turcotte-pugh score from a national electronic healthcare database. Clin Gastroenterol Hepatol 2015;13:2333-41.e1-6.
33. Alberino F, Gatta A, Amodio P, Merkel C, Di Pascoli L, et al. Nutrition and survival in patients with liver cirrhosis. Nutrition
2001;17:445-50.
34. Paine CH, Biggins SW, Pichler RH. Albumin in cirrhosis: more than a colloid. Curr Treat Options Gastroenterol 2019;17:231-43.
35. Wujtewicz M, Dylczyk-Sommer A, Aszkiełowicz A, Zdanowski S, Piwowarczyk S, et al. COVID-19 - what should anaethesiologists and
intensivists know about it? Anaesthesiol Intensive Ther 2020;52:34-41.
36. Alhazzani W, Møller MH, Arabi YM, Loeb M, Gong MN, et al. Surviving sepsis campaign:Guidelines on the management of critically ill
adults with Coronavirus Disease 2019 (COVID-19). Intensive Care Med 2020;46:854-87.
37. Elmaouhoub A, Dudas J, Ramadori G. Kinetics of albumin- and alpha-fetoprotein-production during rat liver development. Histochem
Cell Biol 2007;128:431-43.
38. Fanali G, di Masi A, Trezza V, Marino M, Fasano M, et al. Human serum albumin: from bench to bedside. Mol Aspects Med
2012;33:209-90.
39. Lin L, Jiang X, Zhang Z, Huang S, Zhang Z, et al. Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection. Gut 2020;69:997-
1001.
40. Lechien JR, Chiesa-Estomba CM, De Siati DR, Horoi M, Le Bon SD, et al. Olfactory and gustatory dysfunctions as clinical presentation
of mild-to-moderate forms of the coronavirus disease(COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol 2020:1-11.
41. Lovato A, de Filippis C. Clinical presentation of COVID-19: a systematic review focusing on upper airway symptoms. Ear Nose Throat J
2020:145561320920762.
42. Russell B, Moss C, Rigg A, Hopkins C, Papa S, et al. Anosmia and ageusia are emerging as symptoms in patients with COVID-19: what
does the current evidence say? Ecancermedicalscience 2020;14:ed98.
43. Baker T, Schell CO, Petersen DB, Sawe H, Khalid K, et al. Essential care of critical illness must not be forgotten in the COVID-19
pandemic. Lancet 2020;395:1253-4.
44. Dreher M, Kersten A, Bickenbach J, Balfanz P, Hartmann B, et al. Charakteristik von 50 hospitalisierten COVID-19-Patienten mit und
ohne ARDS. Deutch Arztebl Int 2020;117:271-8.
45. Ramadori G, Christ B. Cytokines and the hepatic acute-phase response. Semin Liver Dis 1999;19:141-55.
46. Buckley MM, O’Brien R, Devlin M, Creed AA, Rae MG, et al. Leptin modifies the prosecretory and prokinetic effects of the
inflammatory cytokine interleukin-6 on colonic function in Sprague-Dawley rats. Exp Physiol 2016;101:1477-91.
47. Goto J, Matsuda K, Harii N, Moriguchi T, Yanagisawa M, et al. Usefulness of a real-time bowel sound analysis system in patients with
severe sepsis (pilot study). J Artif Organs 2015;18:86-91.
48. Groves HT, Higham SL, Moffatt MF, Cox MJ, Tregoning JS. Respiratory Viral Infection Alters the Gut Microbiota by Inducing